NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/09/2024
Back to search
Official data from USPTO
KLUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
04/10/2024
Trademark type
Word
Nice classes
42
Filing date
05/25/2017
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
04/16/2016
First use in commerce
04/16/2016
Drawing code
4
Owner type
99
Owner location
Chengdu, Sichuan, CN
Examiner
BUKER, RACHEL EVE
Law office
N50
Current location
TMO LAW OFFICE 123
Holders and representatives
Holders
Sichuan Kelun Pharmaceutical Co., Ltd.
Representatives
Wansheng Jerry Liu, Esq. FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; research and development for new chemical entitiesnew biological entitiesbiosimilarsgeneric drugsnew drug delivery systems; medical and scientific research in the field of pharmaceutical studies; and technical consulting in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
19 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/09/2024
E815
TEAS SECTION 8 & 15 RECEIVED
10/12/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/03/2017
ALIE
ASSIGNED TO LIE
09/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/25/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/25/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/25/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/25/2017
DOCK
ASSIGNED TO EXAMINER
08/25/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2017
NWAP
NEW APPLICATION ENTERED
05/29/2017
Continuous trademark protection
Get notified about every new filing that threatens KLUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.